U.S. Cancels $590 Million Deal with Moderna for Bird Flu Vaccine Development
The U.S. government has canceled a $590 million contract with Moderna for developing an H5N1 bird flu vaccine, raising questions about future pandemic preparedness efforts amid political controversy.
In a recent development, the United States government has officially canceled a $590 million contract with Moderna, a leading biotech company, intended for the development of an avian influenza vaccine. The contract, initially announced on January 17, was aimed at creating an mRNA vaccine targeting the H5N1 bird flu strain, which has been detected circulating among birds and cattle. Experts have expressed concern about the potential of this virus to cross the species barrier and cause a human pandemic.
The cancellation comes during a period of political controversy, with insights suggesting that the move may be linked to opposition from Health Secretary Robert F. Kennedy Jr., who has a history of spreading misinformation regarding vaccines and immunizations. Despite the halt in funding, Moderna announced positive interim results from a Phase 1/2 clinical trial involving 300 participants, which evaluated the vaccine's safety and immune response.
Moderna's CEO, Stephane Bancel, stated that while the loss of government funding introduces uncertainties, the company remains optimistic about the vaccine’s potential, exploring alternative avenues to advance the project. The clinical data underscores the significance of mRNA technology in addressing emerging infectious diseases, including pandemic influenza.
Public health experts, including Dr. Ashish Jha, have criticized the decision, emphasizing the importance of mRNA vaccines, especially given their role during the COVID-19 pandemic. Jha highlighted the impact of Operation Warp Speed, which facilitated the rapid development of mRNA vaccines under President Trump's administration.
This shift raises questions about future strategies for developing vaccines against rapidly emerging viral threats and highlights the evolving landscape of public-private partnerships in pandemic preparedness.
Source: https://medicalxpress.com/news/2025-05-cancels-million-moderna-bird-flu.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Workload Stress Among Pharmacists Linked to Increased Medication Errors
A new study links pharmacist overwork and systemic workplace flaws to increased medication dispensing errors, emphasizing the need for improved work conditions and systemic reforms to enhance patient safety.
Understanding Thyroid Cancer Risks in Women and Men
Learn about the risks, symptoms, and treatment options for thyroid cancer in both women and men, with recent insights highlighting that the danger is equal for both genders, especially in advanced cases.
Understanding the Rise of DNA Testing by Australian Health Insurers
Australian health insurers are now providing DNA tests to predict individual responses to medications, raising important questions about data security, ethical use, and future health screening. Learn what you need to know about this emerging trend.
Revolutionary AI Technology Identifies Small Brain Lesions in Children with Epilepsy
A new AI tool developed at Murdoch Children's Research Institute significantly improves the detection of small brain lesions responsible for epilepsy in children, enabling faster diagnosis and treatment.